Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9
September 11 2017 - 8:00AM
Business Wire
-- Gene Editing Technology Will Enable Rapid
Development of Nutrition and Ag Productivity Traits --
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural
technology company, announced today that it has signed a global
licensing agreement with the Broad Institute of MIT and Harvard for
research use of the CRISPR-Cas9 genome-editing technology in
agriculture. The technology will enable Arcadia to accelerate the
research and development of its agricultural nutrition and
productivity traits.
CRISPR-Cas9 works by making precisely-targeted modifications in
a cell's DNA, allowing scientists to rapidly enhance beneficial
traits or remove undesired plant characteristics. Arcadia will
initially focus on applying the technology to speed development of
nutritional traits in wheat.
“CRISPR-Cas9 is a high-throughput, cost-effective development
tool that is complementary to our ongoing TILLING and transgenic
development platforms,” said Raj Ketkar, president and CEO of
Arcadia. “We expect this technology will significantly improve the
time-to-market for a number of our innovative traits addressing
large-acre, high-value crops.”
The Broad Institute is a world leader in the development and
sharing of CRISPR genome-editing technologies and holds several
issued U.S. patents covering CRISPR-Cas technology. Under the
agreement announced today, the Broad Institute grants Arcadia a
worldwide non-exclusive research use license for applications of
the CRISPR-Cas9 technology in core Arcadia crops. Additional terms
of the agreement were not disclosed.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA)
develops agricultural products that create added value for farmers
while benefitting the environment and enhancing human health.
Arcadia’s agronomic performance traits, including Nitrogen Use
Efficiency, Water Use Efficiency, Salinity Tolerance, Heat
Tolerance and Herbicide Tolerance, are all aimed at making
agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are
aimed at creating healthier ingredients and whole foods with lower
production costs. For more information, visit
www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements relating to the company’s products and
the regulatory process for such products. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ materially, and reported results should
not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the
company’s and its partners’ and affiliates’ ability to identify and
isolate desired traits; the company’s and its partners’ ability to
develop commercial products incorporating those traits, and
complete the regulatory review process for such products; the
company’s compliance with laws and regulations that impact the
company’s business, and changes to such laws and regulations; the
company’s future capital requirements and ability to satisfy its
capital needs; and the other risks set forth in the company’s
filings with the Securities and Exchange Commission from time to
time, including the risks set forth in the company’s Annual Report
on Form 10-K for the year ended December 31, 2016. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170911005305/en/
Arcadia Biosciences, Inc.Jeff Bergau,
+1-312-217-0419jeff.bergau@arcadiabio.com
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Apr 2023 to Apr 2024